Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
FEBS Letters
|
June 22, 1987
Alkyl analogs of diacylglycerol as activators of protein kinase C
F Heymans, C Da Silva, N Marrec, et al.
Biochimica Et Biophysica Acta
|
August 20, 1991
PAF-receptor. III. Conformational and electronic properties of PAF-like agonists and antagonists
J Lamotte-Brasseur, G Dive, A Lamouri, et al.
Bioorganic & Medicinal Chemistry
|
September 26, 2000
Structure-activity relationships on adrenoceptors and imidazoline-preferring binding sites (I(1,2)-PBSs). Part 1: Weak intramolecular H-bond and conformational flexibility in a new I1-PBS-selective imidazoline analogue, trans1-(4',5'-dihydro-1'H-imidazol-2'-yl)methyl-2-hydroxyindane (PMS 952)
H F Ye, G Dive, D Dehareng, et al.
Journal of Medicinal Chemistry
|
August 1, 1985
Structure-activity relationship in PAF-acether. 2. rac-1-O-Octadecyl-2-O-acetyl-3-O-[gamma-(dimethylamino)propyl]glycerol
F Heymans, M C Borrel, C Broquet, et al.
Prostaglandins, Leukotrienes, and Medicine
|
March 1, 1987
Endothelium-dependent vasorelaxation induced by Cn-acetal plasmalogens
P Braquet, C Broquet, M Auguet, et al.
Agents and Actions
|
December 1, 1981
Synthesis and biological activity of some structural analogs of platelet-activating factor (PAF-acether)
M Ténce, E Michel, E Coeffier, et al.
Lipids
|
December 1, 1991
PAF receptor structure: a hypothesis
J J Godfroid, G Dive, J Lamotte-Brasseur, et al.
Biochemical Pharmacology
|
March 22, 1996
4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors
M Aitdafoun, C Mounier, F Heymans, et al.
Journal of Lipid Mediators and Cell Signalling
|
July 1, 1997
A new phospholipase A2 inhibitor, unrelated to substrate analogues: kinetic characterization of the inhibition of secretory phospholipases A2 by PMS 832
C Binisti, C Mounier, E Touboul, et al.
Journal of Lipid Mediators and Cell Signalling
|
January 1, 1997
Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibition
C Binisti, E Touboul, C Mounier, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
FEBS Letters
|
June 22, 1987
Alkyl analogs of diacylglycerol as activators of protein kinase C
F Heymans, C Da Silva, N Marrec, et al.
Biochimica Et Biophysica Acta
|
August 20, 1991
PAF-receptor. III. Conformational and electronic properties of PAF-like agonists and antagonists
J Lamotte-Brasseur, G Dive, A Lamouri, et al.
Bioorganic & Medicinal Chemistry
|
September 26, 2000
Structure-activity relationships on adrenoceptors and imidazoline-preferring binding sites (I(1,2)-PBSs). Part 1: Weak intramolecular H-bond and conformational flexibility in a new I1-PBS-selective imidazoline analogue, trans1-(4',5'-dihydro-1'H-imidazol-2'-yl)methyl-2-hydroxyindane (PMS 952)
H F Ye, G Dive, D Dehareng, et al.
Journal of Medicinal Chemistry
|
August 1, 1985
Structure-activity relationship in PAF-acether. 2. rac-1-O-Octadecyl-2-O-acetyl-3-O-[gamma-(dimethylamino)propyl]glycerol
F Heymans, M C Borrel, C Broquet, et al.
Prostaglandins, Leukotrienes, and Medicine
|
March 1, 1987
Endothelium-dependent vasorelaxation induced by Cn-acetal plasmalogens
P Braquet, C Broquet, M Auguet, et al.
Agents and Actions
|
December 1, 1981
Synthesis and biological activity of some structural analogs of platelet-activating factor (PAF-acether)
M Ténce, E Michel, E Coeffier, et al.
Lipids
|
December 1, 1991
PAF receptor structure: a hypothesis
J J Godfroid, G Dive, J Lamotte-Brasseur, et al.
Biochemical Pharmacology
|
March 22, 1996
4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors
M Aitdafoun, C Mounier, F Heymans, et al.
Journal of Lipid Mediators and Cell Signalling
|
July 1, 1997
A new phospholipase A2 inhibitor, unrelated to substrate analogues: kinetic characterization of the inhibition of secretory phospholipases A2 by PMS 832
C Binisti, C Mounier, E Touboul, et al.
Journal of Lipid Mediators and Cell Signalling
|
January 1, 1997
Structure-activity relationships in platelet activating factor. 9. From PAF-antagonism to PLA2 inhibition
C Binisti, E Touboul, C Mounier, et al.
Page
of 5